RGT-274-CR

N/A

Report date: 2026/04/13 20:02:18
NME

Base Information

Drug NameRGT-274-CR
Drug Alias NameRGT-274-CRRGT274CRRGT274RGT-274
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesQILU Regor Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesQILU Regor Therapeutics Inc
Inactive CompaniesRegor Therapeutics Group
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A